TARO FDA Approval ANDA 211521

ANDA 211521

TARO

FDA Drug Application

Application #211521

Application Sponsors

ANDA 211521TARO

Marketing Status

Prescription001

Application Products

001FOR SUSPENSION;ORALEQ 200MG BASE/5ML0AZITHROMYCINAZITHROMYCIN

FDA Submissions

UNKNOWN; ORIG1AP2019-12-11STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

TARO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211521
            [companyName] => TARO
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 200MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/11\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-12-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.